Trial
NCT00311558
Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
The Cleveland Clinic
Collaborators
National Cancer Institute (NCI)
Condition
Cancer
Intervention
recombinant interferon alfa-2b
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-26